VTGN: Ascending Triangle (71%), Bullish Pennant (136%)

NASDAQ:VTGN   VistaGen Therapeutics, Inc.
Primary Target (short term):
Ascending Triangle (71%)
PT = 4.39$

Secondary Target (Long term):
Bullish Pennant, confirmed (136%)
PT = 4.61$

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.